Dual Targeting VEGF/Ang3 Surrobody in an Experimental Model of Neovascularization

Related

• 

  What Happens to Diabetic Retinopathy Severity Scores With Less Aggressive Treatment? A Post Hoc Analysis of the RISE and RIDE Open Label Extension Study

  Roger A. Goldberg, MD, MBA

  Updates from the Field

  2019

• 

  Episode 8: DAVE Trial: Targeted Retinal Photocoagulation for DME with Dr. David Brown

  Keyvan Koushan, MD, FRCSC

  Member Podcasts

  2018

• 

  Journal Club with Dr. Ferhina Ali and Dr. Daniel Chao Discussing Caffeine and Beta Blockers for Vitreoretinal Surgeons, Cost-Savings with Intravitreal Bevacizumab, and more

  Jayanth Sridhar, MD

  Daniel L Chao, MD, PhD

  Ferhina S Ali, MD, MPH

  Member Podcasts

  2020